Trial record 1 of 1 for:    NCT01019551
Previous Study | Return to List | Next Study

Therapeutic Intensification Plus Immunomodulation in HIV-infected Patients (ERAMUNE-01)

This study has been completed.
Cytheris SA
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Objectif Recherche Vaccins SIDA Identifier:
First received: November 23, 2009
Last updated: June 12, 2013
Last verified: June 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2013
  Primary Completion Date: July 2012 (Final data collection date for primary outcome measure)